Unlock instant, AI-driven research and patent intelligence for your innovation.

Small molecule noncoding RNA gene hsa-mir-101 and antineoplastic use thereof

A nucleic acid and drug technology, applied in the direction of anti-tumor drugs, DNA / RNA fragments, recombinant DNA technology, etc., can solve the problems of hsa-miR-101 and primary liver cancer research reports, and reduce proliferation and tumor formation Ability, Sensitivity-Promoting Effects

Inactive Publication Date: 2010-06-02
SUN YAT SEN UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] After searching the domestic and foreign literature of the prior art, so far there is no research report on the relationship between hsa-miR-101 and primary liver cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Small molecule noncoding RNA gene hsa-mir-101 and antineoplastic use thereof
  • Small molecule noncoding RNA gene hsa-mir-101 and antineoplastic use thereof
  • Small molecule noncoding RNA gene hsa-mir-101 and antineoplastic use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1: Detection of expression level of hsa-miR-101 in liver cancer tissue samples

[0015] Total RNA was extracted from liver cancer and non-cancerous liver tissues, RNA samples were mixed with RNA loading buffer at a ratio of 3:1, denatured at 80°C for 10 min, and then placed on ice for 5 min; Under the electric power of 10W, use 15% denatured polyacrylamide gel for about 40 minutes for electrophoresis separation; after the electrophoresis is completed, the corners of the gel are marked, and the gel and membrane are assembled in a semi-dry transfer tank in sequence, and the constant current 8mA / cm 2 Transfer to the membrane for 1 hour; remove the Hybond N+ nylon membrane and mark the corners, 70,000μJ / cm 2 UV cross-linking, and then dry-bake at 80°C for 2 hours; wet the nylon membrane with 2×SSC, spread it on the inner wall of the hybridization tube, drive away the air bubbles between the membrane and the tube wall, add the pre-hybridization solution, and put it ...

Embodiment 2

[0017] Example 2: Overexpression of hsa-miR-101

[0018] The small molecule RNA of hsa-miR-101 is introduced into the cells by inversion using Invitrogen’s transfection reagent Lipofectamine RNAi MAX. Taking 24-well plates as an example, other well plates can be scaled up according to the size of the wells. Or shrink: trypsinize cells, resuspend in DMEM without double antibody containing 10% FBS, make the cell density 3×10 4 cells / ml; dilute small molecule RNA in 100 μl opti-MEM, tap the tube wall to mix; add 1 μl Lipofectamine RNAi MAX to each tube, tap the tube wall to mix, and place at room temperature for 15 minutes; add RNAiMAX / siRNA diluent Into the 24-well plate, and then add 500 μl of cell diluent (to make the cell density about 30-50% confluent after 24 hours of transfection), mix well, culture in the incubator for a certain period of time, and then perform relevant function tests.

Embodiment 3

[0019] Example 3: Cell Apoptosis Detection

[0020] After the cells were treated as required, the culture supernatant was aspirated, fixed with 4% paraformaldehyde at room temperature for 15 min, stained with 1 μg / ml (final concentration) DAPI staining solution at room temperature for 5 min, and then observed under a Leica fluorescence microscope for nuclear morphology. Cells with chromatin condensation and DNA fragmentation are considered to be apoptotic cells, and the apoptosis rate is calculated according to the following method:

[0021] Apoptotic rate (%) = number of apoptotic cells / total number of cells (total number of cells ≥ 500)

[0022] We detected the effect of hsa-miR-101 on tumor cell apoptosis under the conditions of serum starvation and chemotherapy drug treatment, and found that the experimental group overexpressing hsa-miR-101 in HepG2 cells (ATCC, USA) was apoptotic after 48 hours of serum starvation. The cell death rate was ~2 times that of the negative co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a small-molecular RNA gene hsa-miR-101 relevant to a primary hepatocellular carcinoma as well as an application thereof. The invention also provides a method for analyzing thecorrelation between the small-molecular RNA gene and the tumor formation and development, as well as purposes of the small-molecular RNA gene hsa-miR-101 at the aspect of primary liver cancer treatment. The invention aims to provide the small-molecular RNA gene hsa-miR-101 acting as the application of tumor therapeutic drugs, and has great practical significance and broad applying prospect in themedical and biopharmaceutical fields.

Description

technical field [0001] The invention relates to a small molecule non-coding RNA gene hsa-miR-101 related to primary liver cancer, and the application of the gene in auxiliary diagnosis and treatment of primary liver cell carcinoma. The invention belongs to the field of biotechnology. technical background [0002] Primary hepatocellular carcinoma is one of the most common malignant tumors in the world. my country is the main place where liver cancer occurs, and the incidence of liver cancer is as high as 35 per 100,000 molecules. In recent years, the incidence of liver cancer has a rising trend, seriously endangering human health and life safety. [0003] MicroRNA (microRNA) is a class of small molecule non-coding ribonucleic acid widely present in various biological species, and its length is about 20-22 bases. It does not encode proteins or polypeptides, but promotes its degradation or inhibits its translation process by specifically binding to the 3'UTR (3' untranslated ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/11A61K31/7088A61P35/00C12N15/113
Inventor 庄诗美苏杭杨建荣杨金娥程家森
Owner SUN YAT SEN UNIV